Mesenchymal stem cell mobilization

Mesenchymal stem cell mobilization refers to the biological process by which mesenchymal stem cells (MSCs) exit their primary niche in the bone marrow or other tissues and migrate through the bloodstream toward sites of tissue injury or inflammation. This migration is regulated by chemokine gradients—most notably involving stromal cell-derived factor 1 (SDF‑1) interacting with CXC chemokine receptor type 4 (CXCR4)—as well as adhesion molecules like P-selectin and CD44. The efficiency of this homing can be enhanced by various strategies including genetic modification, priming with soluble factors, or altering culture conditions. While this process is critical for regenerative medicine applications using MSCs for tissue repair and immunomodulation, “mesenchymal stem cell mobilization” is not itself a discrete molecular target such as a receptor or enzyme, but rather describes a complex physiological event involving multiple molecular players[2][3][4]. “Upon tissue damage, MSCs are immediately mobilized from the bone marrow and move to the injury site via blood circulation... Notably, allogenically transplanted MSCs can also home to the damaged tissue site.”[3] “G protein-coupled chemokine receptors facilitate... activation... The critical factor for this step is stromal cell-derived factor‑1 expression on endothelial cells interacting with CXC chemokine receptors type 4 expressed by MSCs.”[2] Because “mesenchymal stem cell mobilization” does not refer to an individual molecule/receptor/target, it should be flagged as incorrect if used in contexts requiring specific drug targets.

Other names

MSC mobilizationMobilization of mesenchymal stem cellsMesenchymal stromal cell mobilization